Overview
Karl Mengel practices in Hochheim, Germany. Mr. Mengel is rated as an Advanced expert by MediFind in the treatment of Acid Sphingomyelinase Deficiency (ASMD). His top areas of expertise are Acid Sphingomyelinase Deficiency (ASMD), Pompe Disease, Niemann-Pick Disease, and Non-Langerhans-Cell Histiocytosis.
His clinical research consists of co-authoring 14 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Acid Sphingomyelinase Deficiency (ASMD).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acid Sphingomyelinase Deficiency (ASMD)
- Niemann-Pick DiseaseMr. Mengel isAdvanced. Learn about Niemann-Pick Disease.
- Pompe DiseaseMr. Mengel isAdvanced. Learn about Pompe Disease.
- Experienced
- Brachydactyly Mononen TypeMr. Mengel isExperienced. Learn about Brachydactyly Mononen Type.
- HistiocytosisMr. Mengel isExperienced. Learn about Histiocytosis.
- Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome)
- Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)
- Non-Langerhans-Cell HistiocytosisMr. Mengel isExperienced. Learn about Non-Langerhans-Cell Histiocytosis.
- ReticulohistiocytomaMr. Mengel isExperienced. Learn about Reticulohistiocytoma.